Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 janv. 2024 08h00 HE | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates

BOTHELL, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) provides an update on the clinical development of its oral first-in-class...
13 avr. 2021 10h05 HE | Source: Orion Biotechnology Canada Ltd.

ORION BIOTECHNOLOGY WELCOMES NEW MEMBERS OF SCIENTIFIC ADVISORY BOARD

Ottawa, Canada, April 13, 2021 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company focused on precision engineering small protein therapeutics, today...
07 janv. 2014 09h06 HE | Source: CU Toxicology

CU Anschutz Medical Campus Enterprise Launches Revolutionary Drug Test That Takes the Guesswork Out of Drug Use and Misuse

DENVER, CO--(Marketwired - Jan 7, 2014) - For the first time, treatment providers will be able to see a complete picture of their patients' drug use and misuse using a revolutionary new drug test...
01 févr. 2012 16h30 HE | Source: Ocera Therapeutics, Inc.

Tranzyme Pharma Secures Additional $9.3 Million Debt Financing

RESEARCH TRIANGLE PARK, N.C., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that it received an additional net $9.3 million in term loan proceeds through an amendment...